GENEVA, Oct. 9 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES filed a patent application (US2026/022285) for “SOLUBLE TISSUE FACTOR, AND ANTIBODIES, FOR DIAGNOSIS, PREVENTION AND TREATMENT OF THROMBOSIS AND RELATED CONDTIONS”. With publication no. WO/2026/213531, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/36
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....